Neurological Surgery Doctors in Reading, PA Accepting Medicare

4 Neurological Surgery doctors found. Showing 1 - 4

Dr. John P Weaver, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2494 Bernville Rd Ste 200, Reading, PA 19605 Phone: 610-378-2557    Fax: 610-208-8839

Gregory Errol Thompson, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2494 Bernville Rd Ste 200, Reading, PA 19605 Phone: 610-378-2557    Fax: 610-208-8839

David Wayne Allen, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2494 Bernville Rd Ste 200, Reading, PA 19605 Phone: 610-378-2557    Fax: 610-208-8839

Kenneth Lloyd Hill Jr., M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2494 Bernville Rd, Suite 200, Reading, PA 19605 Phone: 610-378-2557    Fax: 610-208-8839

News Archive

Armband labeling could prevent DNR confusion

Implementation of an electronic ordering and armband labeling process for patients with Do Not Resuscitate orders improved correct documentation of their wishes as well as physicians' ability to recognize and act on them during a cardiac arrest scenario, report US researchers.

AGA guidelines recommend anti-TNF-α biologic agents to induce remission in Crohn's disease patients

The anti-TNF-α biologic agents, such as infliximab or adalimumab, are recommended to induce remission in patients with moderately severe Crohn's disease , according to a new guideline from the American Gastroenterological Association. Additionally, the guidelines recommend against using thiopurines or methotrexate alone to induce remission in these patients. The new guideline and accompanying technical review have been published in Gastroenterology, the official journal of the AGA Institute.

Fogarty receives three grants for research focused on biodiversity conservation

In addition to diseases for which there are ineffective or no cures, key pathogens are becoming increasingly drug-resistant.

BioTrends tracks uptake of Yervoy and Zelboraf for advanced melanoma

BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, has released findings from the second wave of its LaunchTrends® Yervoy and Zelboraf report, in which 103 U.S.-based medical oncologists were surveyed about their current and expected treatment patterns in advanced melanoma.

Neanderthal gene variant increases risk of severe COVID-19

Researchers in Germany have conducted a study showing that between 2 and 8% of people in Eurasia carry a genetic variant inherited from Neanderthals that significantly increases the risk of becoming critically ill with coronavirus disease 2019 (COVID-19).

Read more Medical News

› Verified 4 days ago